Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Ardelyx is a US-based biopharmaceutical company dedicated to the development of innovative therapies for patients with kidney disease. By leveraging novel mechanisms of action, the company specifically addresses significant unmet medical needs through its targeted therapeutic approach.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Ardelyx is scheduled to report its next quarterly earnings on 10/29/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Ardelyx last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.07 USD.
Ardelyx has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.